首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Quinoline derivatives bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents
【24h】

Quinoline derivatives bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents

机译:含吡唑部分的喹啉衍生物:合成和生物学评估作为可能的抗菌和抗真菌剂

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract In an attempt for development of new antimicrobial agents, three series of quinoline derivatives bearing pyrazole moiety have been synthesized. The first series was synthesized through the synthesis of 4-(quinolin-2-yloxy)benzaldehyde and 4-(quinolin-2-yloxy)acetophenone and then treatment with ketone or aldehyde derivatives to afford the corresponding chalcones. Cyclization of the latter chalcones with hydrazine derivatives led to the formation of new pyrazoline derivatives. The second series was synthesized via the synthesis of 2-hydrazinylquinoline and then treatment with formylpyrazoles to afford the corresponding hydrazonyl pyrazole derivatives. The third series was synthesized through the treatment of 2-hydrazinylquinoline with ethoxyethylidene, dithioacetal and arylidene derivatives to afford the corresponding pyrazole derivatives. The synthesized compounds were evaluated for their expected antibacterial and antifungal activities; where, the majority of these compounds showed potent antibacterial and antifungal activities against the tested strains of bacteria and fungi. Pyrazole derivative 13b showed better results when compared with the reference drugs as revealed from their MIC values (0.12–0.98?μg/mL). The pyrazole derivative 13b showed fourfold potency of gentamycin in inhibiting the growth of S.?flexneri (MIC 0.12?μg/mL). Also, compound 13b showed fourfold potency of amphotericin B in inhibiting the growth of A.?clavatus (MIC 0.49?μg/mL) and C.?albicans (MIC 0.12?μg/mL), respectively. The same compound showed twofold potency of gentamycin in inhibiting the growth of P.?vulgaris (MIC 0.98?μg/mL), equipotent to the ampicillin and amphotericin B in inhibiting the growth of S.?epidermidis (MIC 0.49?μg/mL), A.?fumigatus (MIC 0.98?μg/mL), respectively. Thus, these studies suggest that quinoline derivatives bearing pyrazole moiety are interesting scaffolds for the development of novel antibacterial and antifungal agents. Graphical abstract New three series of quinoline derivatives bearing a pyrazole moiety have been synthesized and evaluated for antibacterial and antifungal activity. Display Omitted Highlights ? Synthesis of chalcones. ? Using the chalcones for synthesizing variously substituted pyrazoles. ? Synthesis of 2-hydrazinylquinoline. ? Using the 2-hydrazinylquinoline for synthesizing variously substituted pyrazoles. ? The antimicrobial activity assay was determined.
机译:摘要在尝试开发新的抗微生物剂,已经合成了含有吡唑部分的三系列喹啉衍生物。通过合成4-(喹啉-2-基氧基)苯甲醛和4-(喹啉-2-基氧基)苯乙酮合成第一个系列,然后用酮或醛衍生物处理,得到相应的硫氨酸。用肼衍生物环化后一种胆碱导致形成新的吡唑啉衍生物。通过合成2-肼基喹啉合成第二系列,然后用甲酰吡唑处理得到相应的氢肼吡唑衍生物。通过用乙氧基亚乙基,二硫代丙酮和亚亚胺衍生物处理2-肼喹啉合成第三系列,得到相应的吡唑衍生物。评价合成化合物的预期抗菌和抗真菌活性;其中大多数这些化合物显示出与测试的细菌和真菌的测试菌株有效的抗菌和抗真菌活动。与从其麦克风值(0.12-0.98Ωμg/ ml)的参考药物相比,吡唑衍生物13b显示出更好的结果。吡唑衍生物13b显示庆祝蛋白蛋白的四倍效力抑制S.FlexNeri的生长(MIC0.12≤μg/ ml)。此外,化合物13b分别显示了两性霉素B的四倍效力,抑制A.?clavatus(MIC0.49≤μg/ ml)和C.? albicans(MIC0.12≤μg/ ml)的生长。相同的化合物显示出庆大霉素的双重效力抑制p.?vulgaris(Mic0.98≤μg/ ml)的生长,抑制氨苄青霉素和两性霉素B抑制S.εpidermidis的生长(MIC0.49≤μg/ ml) ,A.?Fumigatus(MIC0.98≤μg/ ml)。因此,这些研究表明,含吡唑部分的喹啉衍生物是有趣的用于开发新型抗菌和抗真菌剂的支架。图解摘要已经合成了新的三系列含有吡唑部分的喹啉衍生物,并评估抗菌和抗真菌活性。显示省略亮点?基氨酸的合成。还是使用Chalcones合成各种取代的吡唑。还是2-肼基喹啉的合成。还是使用2-肼喹啉合成各种取代的吡唑。还是确定抗微生物活性测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号